Antibacterial properties studies of trunk barks of terminalia ivorensis (Combretaceae), a commercial and medicinal specie, on some methicillin-resistant Staphylococci spp strains.

Background: Methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis and coagulase-negative Staphylococcus infections are a worldwide concern. Terminalia ivorensis, of Combretaceae family plant, is widely used traditional medicinal in Côte d’Ivoire to treat dermal diseases (affection in which Staphylococci are implied) including local inflammation and also to treat voice-loss.Objectives: This study focused to investigate the effect in vitro of the extracts of trunk barks of Terminalia ivorensis on some methicillin/oxacillin-resistant strains of Staphylococcus aureus, S. epidermidis, coagulase-negative S. and reference strain of S. aureus ATCC 25923.Methods: Antibacterial activity of aqueous, 70% ethanolic 70% and aqueous residue extracts was assessed using agar disc-diffusion method and liquid medium microdilution method in 96 multi-well micro-titer plates. This method led us to determine minimum inhibition concentration (M.I.C.) and minimum bactericidal concentration (M.B.C.). The presence of chemical groups major was detected qualitatively.Results: Aqueous and 70% ethanolic 70% extracts showed significant activity against all the bacteria except aqueous residue when compared with the standard antibiotic oxacillin (5μg/ml). M.I.C. for aqueous and 70% ethanolic 70% extracts ranged from 0,83-16,67 mg/ml and 0,156-13,33 mg/ml respectively. Viable cell determination revealed the bactericidal nature of the two barks extracts. The 70% ethanolic 70% extract exhibited the highest activity according to the M.B.C. values. The phytochemical analysis indicates the presence of tannins, saponins, flavonoids, terpen/sterols, coumarins, polyphenols and traces of alkaloid.Conclusion: The in-vitro antibacterial efficacy shown by the barks of this plant and his lushness in chimical compounds, would justify use of this one in the traditional treatment of some diseases of microbial origin. These compounds could be suggested to provide alternative solution to the development of new therapeutic agents.Keys words: Terminalia ivorensis, Dermal diseases, Methicillin-resistant, Côte d’Ivoire

Effet antibactérien de l’extrait aqueux de l’écorce de Terminalia glaucescens Planch ex Benth (Combretaceae) sur la croissance in vitro des entérobactéries productrices de bêta-lactamases à spectre élargi (EBLSE)

Les bacteries productrices de beta-lactamases a spectre elargi sont responsables des echecs therapeutiques a infection bacterienne. Cette etude vise a evaluer les effets antibacteriens de lfextrait aqueux du macere d'fecorce de tige de Terminalia glaucescens Planch ex Benth (Combretaceae) sur huit enterobacteries productrices de beta-lactamases a spectre elargi (EBLSE) et deux souches de reference de Escherichia coliATCC. Les methodes de diffusion et de dilution sur Muller-Hinton ont permis dfevaluer l'factivite antibacterienne de l'fextrait. L'factivite  antibacterienne in vitro de l'fextrait aqueux de l'fecorce de tige de T.glaucescens est plus elevee que celle de la ceftriaxone (30 µg) et de la cefotaxime (30 µg) vis-a-vis des souches bacteriennes. Toutes ces souches sont resistantes aux deux antibiotiques, a l''fexception de celles de E. coli ATCC 25922 et 35218. L'fextrait aqueux de T. glaucescens est actif sur les 10 souches. Les zones d'finhibition a 200 mg/ml sont comprises entre 13±0,6 a 19,3±0,6 mm. Les CMI de l'extrait aqueux varient de 1,56 a 50 mg/ml. L'fextrait est bactericide sur toutes les souches apres 24 et 48 heures d'fincubation. Cette etude a montre que l'extrait de T. glaucescens pourrait etre utilise dans le traitement des maladies infectieuses.Mots cles: Terminalia glaucescens, extrait aqueux, activite antibacterienne